VAR2 Pharmaceuticals has received an extended Knowledge Voucher from Danish Council for Technology and Innovation.

The Voucher will be used to establish a collaboration between researchers at University of Copenhagen and Bioneer with the aim at optimizing production methods and stability of our proprietary cancer targeting molecules prior to GMP production for the first human clinical trials.